Use of limited proteolysis to identify protein domains suitable for structural analysis.

Publisher Summary This chapter explains the use of limited proteolysis to identify protein domains suitable for structural analysis. The field of structural proteomics arose with the availability of complete genomic sequences for several organisms and high-throughput methods to purify recombinant forms of their proteins. The aim of this research area is to solve the structure of every protein using either experimental or computational methods. Moreover, there is an overall bias in these studies with the vast majority of solved structures representing peptides less than 30 kDa in size. This bias may reflect the initial selection process of candidate genes or the greater propensity for smaller peptides to yield samples suitable for crystallography or nuclear magnetic resonance (NMR) spectroscopy. This chapter illustrates that for NMR analyses intrinsic limitations on the size of molecules that can be studied often necessitate analysis of individual domains. Protein domains have additional features that render them attractive targets for structural analysis. Finally, this chapter demonstrates that domain mapping by limited proteolysis is a powerful complement to the more common methods of sequence conservation and deletion mutagenesis. The process is rapid, requires minimal sample handling, and is highly adaptable to high-throughput analysis.

[1]  M. Gerstein,et al.  Assessing annotation transfer for genomics: quantifying the relations between protein sequence, structure and function through traditional and probabilistic scores. , 2000, Journal of molecular biology.

[2]  Sung-Hou Kim Shining a light on structural genomics , 1998, Nature Structural Biology.

[3]  Cheryl H. Arrowsmith,et al.  Protein production: feeding the crystallographers and NMR spectroscopists , 2000, Nature Structural Biology.

[4]  M Wilm,et al.  Electrospray mass spectrometry for protein characterization. , 1995, Trends in biochemical sciences.

[5]  A. Sali 100,000 protein structures for the biologist , 1998, Nature Structural Biology.

[6]  Mark Gerstein,et al.  Structural proteomics of an archaeon , 2000, Nature Structural Biology.

[7]  William Arbuthnot Sir Lane,et al.  Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II , 1995, Science.

[8]  Steven L. Cohen,et al.  Probing the solution structure of the DNA‐binding protein Max by a combination of proteolysis and mass spectrometry , 1995, Protein science : a publication of the Protein Society.

[9]  R. Pfuetzner,et al.  Replication Protein A , 1997, The Journal of Biological Chemistry.

[10]  M Gerstein,et al.  Structural proteomics: prospects for high throughput sample preparation. , 2000, Progress in biophysics and molecular biology.

[11]  C. Arrowsmith,et al.  Yeast Transcript Elongation Factor (TFIIS), Structure and Function , 1998, The Journal of Biological Chemistry.

[12]  A human cDNA encoding the 110-kDa A subunit of RNA polymerase II transcription factor elongin. , 1996, Gene.

[13]  R. Conaway,et al.  The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex. , 1996, The EMBO journal.

[14]  R. Pfuetzner,et al.  Overexpression, Purification, and Crystallization of the DNA Binding and Dimerization Domains of the Epstein-Barr Virus Nuclear Antigen 1 (*) , 1995, The Journal of Biological Chemistry.

[15]  R. Conaway,et al.  Elongin from Saccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.